Filing Details
- Accession Number:
- 0001209191-23-055621
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-16 19:39:55
- Reporting Period:
- 2023-11-14
- Accepted Time:
- 2023-11-16 19:39:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1966494 | Cargo Therapeutics Inc. | CRGX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1253170 | Srinivas Akkaraju | 628 Middlefield Road Palo Alto MA 94301 | No | No | Yes | No | |
| 1699737 | Samsara Biocapital, L.p. | 628 Middlefield Road Palo Alto MA 94301 | No | No | Yes | No | |
| 1888829 | Samsara Biocapital Gp, Llc | 628 Middlefield Road Palo Alto MA 94301 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-14 | 3,381,323 | $0.00 | 3,455,023 | No | 4 | C | Indirect | By Samsara BioCapital, L.P. |
| Common Stock | Acquisiton | 2023-11-14 | 666,666 | $15.00 | 4,121,689 | No | 4 | P | Indirect | By Samsara BioCapital, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Samsara BioCapital, L.P. |
| No | 4 | P | Indirect | By Samsara BioCapital, L.P. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series Seed convertible preferred stock | Disposition | 2023-11-14 | 663,300 | $0.00 | 663,300 | $0.00 |
| Common Stock | Series A-1 convertible preferred stock | Disposition | 2023-11-14 | 884,400 | $0.00 | 884,400 | $0.00 |
| Common Stock | Series A-2 convertible preferred stock | Disposition | 2023-11-14 | 1,833,623 | $0.00 | 1,833,623 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
- Shares are held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein.
Billionaire Hedge Funds
